| Primary |
| Acute Lymphocytic Leukaemia |
23.8% |
| Multiple Myeloma |
16.6% |
| Histiocytosis Haematophagic |
7.8% |
| Anaesthesia |
6.2% |
| Prophylaxis Of Nausea And Vomiting |
5.2% |
| Nausea |
4.7% |
| Vomiting |
4.7% |
| Acute Lymphocytic Leukaemia Recurrent |
4.1% |
| Musculoskeletal Pain |
3.1% |
| Oesophageal Carcinoma |
3.1% |
| General Anaesthesia |
2.6% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
2.6% |
| T-cell Lymphoma |
2.6% |
| 21-Hydroxylase Deficiency |
2.1% |
| Diabetes Mellitus |
2.1% |
| Hypertension |
2.1% |
| Scan Adrenal Gland |
2.1% |
| Anaplastic Astrocytoma |
1.6% |
| Antiviral Prophylaxis |
1.6% |
| Asthma |
1.6% |
|
| Varicella |
20.0% |
| Epstein-barr Virus Infection |
7.3% |
| Jaundice |
5.5% |
| Periventricular Leukomalacia |
5.5% |
| Pneumonitis |
5.5% |
| Premature Baby |
5.5% |
| Sepsis |
5.5% |
| Drug Ineffective |
3.6% |
| Hepatitis B |
3.6% |
| Lung Adenocarcinoma Metastatic |
3.6% |
| Meningitis Cryptococcal |
3.6% |
| Overdose |
3.6% |
| Paranoia |
3.6% |
| Peripheral Ischaemia |
3.6% |
| Phaeochromocytoma |
3.6% |
| Pustular Psoriasis |
3.6% |
| Sinus Tachycardia |
3.6% |
| Tumour Lysis Syndrome |
3.6% |
| Vomiting |
3.6% |
| Acute Psychosis |
1.8% |
|
| Secondary |
| Vomiting |
16.1% |
| Nausea |
13.7% |
| 21-Hydroxylase Deficiency |
11.7% |
| Drug Use For Unknown Indication |
6.8% |
| Multiple Myeloma |
6.3% |
| Insomnia |
5.9% |
| T-cell Lymphoma |
4.4% |
| Anaesthesia |
3.9% |
| Lymphoma |
3.4% |
| Anxiety |
2.9% |
| Asthma |
2.9% |
| Brain Oedema |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Lung Adenocarcinoma |
2.9% |
| Musculoskeletal Pain |
2.9% |
| General Anaesthesia |
2.4% |
| Rash |
2.4% |
| Scan Adrenal Gland |
2.0% |
| Stem Cell Transplant |
2.0% |
| Anaplastic Astrocytoma |
1.5% |
|
| Overdose |
29.8% |
| Hypokalaemia |
10.6% |
| Vomiting |
8.5% |
| Drug Exposure During Pregnancy |
6.4% |
| Obesity |
6.4% |
| Phaeochromocytoma |
4.3% |
| Sinus Tachycardia |
4.3% |
| Weight Increased |
4.3% |
| Anaphylactoid Reaction |
2.1% |
| Disease Progression |
2.1% |
| Duodenal Ulcer |
2.1% |
| Hypophosphataemia |
2.1% |
| Malaise |
2.1% |
| Meningitis Cryptococcal |
2.1% |
| Multiple Myeloma |
2.1% |
| Nausea |
2.1% |
| Plasmacytoma |
2.1% |
| Pneumocystis Jiroveci Pneumonia |
2.1% |
| Pulmonary Artery Thrombosis |
2.1% |
| Pulmonary Embolism |
2.1% |
|
| Concomitant |
| Premedication |
20.8% |
| Drug Use For Unknown Indication |
14.8% |
| Multiple Myeloma |
8.7% |
| Non-small Cell Lung Cancer |
6.9% |
| Nausea |
5.8% |
| Cough |
5.3% |
| Anorexia |
4.1% |
| Hypertension |
3.5% |
| Glioblastoma Multiforme |
3.3% |
| Constipation |
3.0% |
| Prophylaxis Of Nausea And Vomiting |
2.9% |
| Breast Cancer Metastatic |
2.8% |
| Prophylaxis |
2.8% |
| Rectal Cancer |
2.7% |
| Colon Cancer |
2.6% |
| Colon Cancer Metastatic |
2.6% |
| Pain |
2.0% |
| Infection Prophylaxis |
1.9% |
| Colorectal Cancer Metastatic |
1.7% |
| Stomatitis |
1.7% |
|
| Vomiting |
15.8% |
| White Blood Cell Count Decreased |
9.2% |
| White Blood Cell Count Increased |
7.9% |
| Rash |
7.2% |
| Respiratory Failure |
5.3% |
| Neuropathy Peripheral |
4.6% |
| Pyrexia |
4.6% |
| Wound Debridement |
4.6% |
| Renal Impairment |
3.9% |
| Sepsis |
3.9% |
| Urinary Incontinence |
3.9% |
| Weight Decreased |
3.9% |
| Blood Magnesium Decreased |
3.3% |
| Hypersensitivity |
3.3% |
| Infusion Related Reaction |
3.3% |
| Pneumonia |
3.3% |
| Thrombocytopenia |
3.3% |
| Urticaria |
3.3% |
| Cardiac Failure |
2.6% |
| Deep Vein Thrombosis |
2.6% |
|
